These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 22645963)

  • 1. [The efficacy of cytoflavin used for the correction of psychoemotional and neuroimmune disturbances in the patients presenting with eczema].
    Laseev DI; Dikova OV
    Klin Med (Mosk); 2012; 90(2):50-3. PubMed ID: 22645963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The use of cytoflavin for the treatment of chronic brucellosis].
    Shul'diakov AA; Liapina EP; Soboleva LA; Reshetnikov AA; Zubareva EV; Trubetskov AD; Anashchenko AV; Evdokimov AV
    Klin Med (Mosk); 2011; 89(2):56-8. PubMed ID: 21574446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Improvement of speech discrimination with cytoflavin in patients with chronic sensorineural deafness].
    Zhuravskiĭ SG
    Vestn Otorinolaringol; 2010; (4):82-6. PubMed ID: 21105353
    [No Abstract]   [Full Text] [Related]  

  • 4. [Efficacy of cytoflavin in the treatment of chronic cerebral ischemia].
    Suslina ZA; Klocheva EG; Piradov MA; Rumiantseva SA; Romantsov MG; Kovalenko AL
    Klin Med (Mosk); 2010; 88(3):50-3. PubMed ID: 20608066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The use of cytoflavin in the complex treatment of patients with tick-borne encephalitis].
    Selezneva AG; Petrova AG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(7):68-9. PubMed ID: 23011438
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical efficacy of cytoflavin in the combined treatment of patients during acute phase of ischemic stroke].
    Shestakov VV; Kosenkova NV; Kichigina EV; Larikova TN; Starikova NL
    Klin Med (Mosk); 2011; 89(1):38-40. PubMed ID: 21516764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The efficiency of cytoflavin and ozonotherapy in complex treatment of the myasthenia].
    Drozd OA; Efremov VV; Dudarev IV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(1):46-9. PubMed ID: 23528494
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacological correction of free radical disturbances and endotoxicosis in patients with diffuse peritonitis at the postoperative period].
    Bagnenko SF; Mirzabaev AT; Batotsyrenov BV; Gorbachev NB; Miroshnichenko VN; Batotsyrenova KhV; Velikiĭ KF
    Vestn Khir Im I I Grek; 2011; 170(5):14-6, 18. PubMed ID: 22238957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of alcohol addiction syndrome with cytoflavin].
    Belov VG; Parfenov IuA; Okovityĭ SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(6 Pt 2):54-7. PubMed ID: 23887469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The use of neurometabolic treatment in the complex rehabilitation in poststroke patients].
    Kovalchuck VV; Khafizova TL; Galkin AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(11):61-6. PubMed ID: 25591638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytoflavin in polychemotherapy of breast cancer].
    Kashuro VA; Glushkov SI; Zheregelia SN
    Antibiot Khimioter; 2010; 55(7-8):30-3. PubMed ID: 21140562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correction of mnestico-intellectual disturbances in the somatogenic phase of acute poisoning with a mixture of psychotropic drugs].
    Shilov VV; Aleksandrov MV; Vasil'ev SA; Batotsyrenov BV; Kuznetsov OA
    Klin Med (Mosk); 2012; 90(3):63-5. PubMed ID: 22690570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The results of using cytoflavin in conservative treatment of patients with obliterating atherosclerosis of the lower extremity vessels].
    Bogomolov MS; Sedov VM; Edovina LN; Luk'ianov IuV; Slobodianiuk VV
    Vestn Khir Im I I Grek; 2011; 170(1):43-6. PubMed ID: 21506354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic possibilities of improvement of cognitive functions, psychoemotional condition and a quality of life in post-stroke patients].
    Kovalchuk VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(12):92-97. PubMed ID: 26978500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oxidative stress and combined antioxidant energy correction in the treatment of periodontitis].
    Omarov IA; Bolevich SB; Savateeva-Liubimova TN; Silina EV; Sivak KV
    Stomatologiia (Mosk); 2011; 90(1):10-7. PubMed ID: 21378714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of cytoflavine in treating traumatic toxicosis].
    Zarubina IV; Iunusov IA; Shabanov PD
    Eksp Klin Farmakol; 2010 Jul; 73(7):23-7. PubMed ID: 20821976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytoflavin in the complex treatment of neuroinfections in children].
    Skripchenko NV; Egorova ES
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(9):28-31. PubMed ID: 22027666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The impaired immune system and ways of its correction in critically ill patients with acute severe intoxication by neutropic poisons].
    Batotsyrenov BV; Livanov GA; Pivovarova LP; Lodiagin AN; Batotsyrenova KhV; Vasil'ev SA
    Anesteziol Reanimatol; 2005; (6):33-4. PubMed ID: 16499103
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of cytoflavin for correction of complications of myocardial infarction].
    Bul'on VV; Khnychenko LK; Sapronov NS; Kovalenko AL; Alekseeva LE
    Eksp Klin Farmakol; 2002; 65(1):27-9. PubMed ID: 12025779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardioprotective effect of cytoflavine on a model of doxorubicin-induced cardiomyopathy].
    Kashuro VA; Glushkov SI; Novikova TM; Aksenov VV
    Eksp Klin Farmakol; 2010 Mar; 73(3):15-7. PubMed ID: 20408423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.